JPI-CEPHALOSPORIN PLANT

JPI-CEPHALOSPORIN PLANT is a manufacturing factory.

Company Introduction:

JPI-CEPHALOSPORIN PLANT is a dedicated pharmaceutical manufacturing facility based in Saudi Arabia. The company specializes in the production of cephalosporin antibiotics, a critical class of broad-spectrum antimicrobial drugs. As a plant, its primary function involves the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms of various cephalosporin compounds. It operates under strict international quality standards to ensure the efficacy, safety, and purity of its pharmaceutical products, serving both the domestic and international healthcare markets. Its establishment contributes significantly to the local pharmaceutical industry and regional healthcare needs by providing essential medicines.

JPI-CEPHALOSPORIN PLANT, operating as part of Jeddah Pharmaceutical Industries (JPI) in Saudi Arabia, produces and sells a range of finished dosage forms of cephalosporin antibiotics. The products typically include:

1. Cefuroxime Axetil in tablet and suspension forms.

2. Cefixime in capsule and oral suspension forms.

3. Cephalexin in capsule and oral suspension forms.

4. Ceftriaxone as sterile powder for injection.

5. Cefazolin as sterile powder for injection.

6. Cefradine in capsule and oral suspension forms.

7. Cefaclor in capsule and oral suspension forms.

8. Other various oral and injectable cephalosporin formulations.